WASHINGTON, D.C. — President Donald J. Trump has announced a groundbreaking executive order aimed at drastically reducing prescription drug prices across the United States. In a statement shared on social media, President Trump revealed his plan to sign what he described as one of the most significant executive orders in American history, targeting the high costs of pharmaceuticals and guaranteeing Americans pay some of the lowest prices for medications worldwide.

“For many years, the world has wondered why prescription drugs and pharmaceuticals in the United States were so much higher in price than they were in any other nation,” President Trump stated. “Sometimes being five to ten times more expensive than the same drug, manufactured in the exact same laboratory or plant, by the same company.”

The executive order, set to be signed in the White House, will mandate price reductions of 30% to 80% on prescription drugs. The policy will be enforced through a “Most Favored Nation’s Policy,” which ensures that the United States will pay the lowest prices for prescription drugs, equivalent to those paid by other countries. Trump emphasized that this measure would not only reduce domestic drug prices but also create a ripple effect, lowering global prices as well.

“Campaign contributions can do wonders, but not with me and not with the Republican Party. We are going to do the right thing,” Trump asserted, criticizing the influence of pharmaceutical companies on American healthcare. He described the U.S. healthcare system as being exploited by “suckers,” with Americans paying inflated prices for essential medications due to pharmaceutical industry lobbying.

Trump’s executive order is a direct response to long-standing complaints that Americans pay significantly more for prescription drugs than citizens of other countries. He condemned pharmaceutical companies for hiding behind research and development costs to justify high prices, despite manufacturing the same drugs in the same facilities for a fraction of the cost in other nations.

The president’s announcement marks a dramatic shift in U.S. pharmaceutical policy, and he emphasized that the changes would have an immediate impact. “Prescription Drug and Pharmaceutical prices will be reduced, almost immediately, by 30% to 80%. They will rise throughout the world in order to equalize and, for the first time in many years, bring fairness to America,” Trump declared.

The executive order also aims to save American taxpayers trillions of dollars while reducing healthcare costs for millions of citizens. “Our country will finally be treated fairly, and our citizens’ healthcare costs will be reduced by numbers never even thought of before,” he added.

The timing of the executive order comes as healthcare remains a central issue for American families facing rising costs. Critics of the pharmaceutical industry have long argued that Americans are being forced to overpay for medications that are available at much lower prices abroad.

Industry analysts are now assessing the potential impact of Trump’s executive order, with some predicting legal challenges from pharmaceutical companies that stand to lose billions in revenue. However, supporters of the order praise it as a long-overdue step toward protecting American consumers from price gouging.

President Trump’s administration has consistently emphasized healthcare reform as a priority, and this latest move aligns with his broader commitment to making prescription drugs more affordable for American families.

As the country awaits the official signing of the executive order, millions of Americans are hopeful that this policy will bring meaningful relief to their healthcare expenses. More details are expected to emerge in the coming days, including how the order will be implemented and which medications will be directly affected.